PDL BioPharma, Inc. Non-operating Income/Expense

Non-operating Income/Expense of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Non-operating Income/Expense growth rates and interactive chart. Income or expense that is usually non-recurring and not tied to a company's operations. It is stated separately on the income statement to differentiate it from operating expenses.


Highlights and Quick Summary

  • Non-operating Income/Expense for the quarter ending June 29, 2020 was $-243 Thousand (a -98.31% decrease compared to previous quarter)
  • Year-over-year quarterly Non-operating Income/Expense decreased by -99.17%
  • Annual Non-operating Income/Expense for 2019 was $26.1 Million (a -589.38% decrease from previous year)
  • Annual Non-operating Income/Expense for 2018 was $-5.33 Million (a -42.42% decrease from previous year)
  • Annual Non-operating Income/Expense for 2017 was $-9.25 Million (a -53.81% decrease from previous year)
  • Twelve month Non-operating Income/Expense ending June 29, 2020 was $13.9 Million (a 8.53% increase compared to previous quarter)
  • Twelve month trailing Non-operating Income/Expense decreased by -142.45% year-over-year
Trailing Non-operating Income/Expense for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$13.9 Million $12.8 Million $26.1 Million $-32.7 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Non-operating Income/Expense of PDL BioPharma, Inc.

Most recent Non-operating Income/Expenseof PDLI including historical data for past 10 years.

Interactive Chart of Non-operating Income/Expense of PDL BioPharma, Inc.

PDL BioPharma, Inc. Non-operating Income/Expense for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $-0.24 $-14.36
2019 $57.84 $-29.35 $-1.33 $-1.08 $26.07
2018 $-0.94 $-1.29 $-1.44 $-1.67 $-5.33
2017 $1.11 $-7.13 $1.53 $-4.76 $-9.25
2016 $-6.91 $-4.35 $-4.33 $-4.44 $-20.03
2015 $1.18 $-5.81 $-7.08 $-8.52 $-20.24
2014 $-9.33 $-9.31 $-9.78 $-16.62 $-45.04
2013 $-10.41 $-6.07 $-5.99 $-2.16 $-24.63
2012 $-7.58 $-4.65 $-7.44 $-8.61 $-28.28
2011 $-8.03 $-8.88 $-10.39 $-8.98 $-36.28
2010 $-8.35 $-12.12 $-27.8 $-60.71

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.